Last updated on February 2018

COMPASSION XT PAS - Post-approval Study of the SAPIEN XT THV in Patients With Pulmonary Valve Dysfunction


Brief description of study

This study will confirm the safety and effectiveness of the Edwards Lifesciences SAPIEN XT Transcatheter Heart Valve (THV) System in patients with a dysfunctional right ventricular outflow tract (RVOT) conduit with a clinical indication for intervention in a post-market setting.

Detailed Study Description

The study is a prospective, non-randomized, multi-center clinical study to assess the safety and effectiveness of pulmonic implantation of the SAPIEN THV in patients with dysfunctional RVOT conduits requiring treatment for moderate or severe pulmonary regurgitation (PR) by transthoracic echocardiography (TTE) and/or RVOT conduit obstruction with a mean gradient of 35 mmHg by TTE.

Clinical Study Identifier: NCT02987387

Find a site near you

Start Over

University of Alabama

Birmingham, AL United States
  Connect »

Sutter Medical Center

Sacramento, CA United States
  Connect »

Rady Children's Hospital

San Diego, CA United States
  Connect »

Children's National Medical Center

Washington, D.C., United States
  Connect »

Nicklaus Children's

Miami, FL United States
  Connect »

Advocate Children's Hospital

Oak Lawn, IL United States
  Connect »

The University of Iowa

Iowa City, IA United States
  Connect »

Children's Heart Center Nevada

Las Vegas, NV United States
  Connect »

Mount Sinai Beth Israel

New York, NY United States
  Connect »

Cincinnati Children's Hospital

Cincinnati, OH United States
  Connect »

UH Rainbow Babies&Children's

Cleveland, OH United States
  Connect »

Cleveland Clinic Foundation

Cleveland, OH United States
  Connect »

Children's Health Dallas

Dallas, TX United States
  Connect »

Texas Children's

Houston, TX United States
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.